Migraine medications

Last updated: November 01, 2022

Migraine medications

M1 Beweging

M1 Beweging

Transient ischemic attack
Stroke: Clinical
Ischemic stroke
Cardiovascular system anatomy and physiology
Introduction to the cardiovascular system
Migraine
Migraine medications
Dizziness and vertigo: Clinical
Headaches: Clinical
Headaches: Pathology review
Seizures: Clinical
Anatomy of the brainstem
Tension headache
Cluster headache
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Bruxism
Trigeminal neuralgia
Anatomy of the trigeminal nerve (CN V)
Sturge-Weber syndrome
Cranial nerves
Peripheral nervous system histology
Central nervous system histology
Ulnar claw
Anatomy clinical correlates: Median, ulnar and radial nerves
Brachial plexus
Vessels and nerves of the forearm
Carpal tunnel syndrome
Anatomy of the arm
Anatomy of the brachial plexus
Muscle weakness: Clinical
Polymyalgia rheumatica
Guillain-Barre syndrome
Demyelinating disorders: Pathology review
Parkinson disease
Anti-parkinson medications
Hypokinetic movement disorders: Clinical
Movement disorders: Pathology review
Seizures and epilepsy
Seizures: Pathology review
Nonbenzodiazepine anticonvulsants
Tourette syndrome
Fragile X syndrome
Hyperkinetic movement disorders: Clinical
Disorders of consciousness: Clinical
Consciousness
Meningitis
Meningitis, encephalitis and brain abscesses: Clinical
Neisseria meningitidis
Central nervous system infections: Pathology review
West Nile virus
Streptococcus pneumoniae
Back pain: Pathology review
Spinal disc herniation
Degenerative disc disease
Sciatica
Brain herniation
Dissociative disorders
Dissociative disorders: Clinical
Anatomy clinical correlates: Vertebral canal
Cauda equina syndrome
Spinal stenosis
Spinal cord reflexes
Spinal cord disorders: Pathology review
Tethered spinal cord syndrome
Ascending and descending spinal tracts
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Anatomy clinical correlates: Spinal cord pathways
Multiple sclerosis
Amyotrophic lateral sclerosis
Normal pressure hydrocephalus
Aqueductal stenosis
Chiari malformation
Dandy-Walker malformation
Congenital neurological disorders: Pathology review
Dementia and delirium: Clinical
Epidural hematoma
Epidural abscess
Subdural hematoma
Traumatic brain injury: Clinical
Adult brain tumors
Brain tumors: Clinical
Adult brain tumors: Pathology review
Neurofibromatosis
Pediatric brain tumors: Pathology review
Brown-Sequard Syndrome
Vertigo: Pathology review
Serotonin and norepinephrine reuptake inhibitors
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Tricyclic antidepressants
Anatomy of the blood supply to the brain
Brain abscess
Anatomy of the cerebral cortex
Motor cortex
Cerebral palsy
Cerebral circulation
Anatomy clinical correlates: Cerebral hemispheres
Cerebral vascular disease: Pathology review
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Nervous system anatomy and physiology
Development of the muscular system
Vestibular transduction
Vestibulo-ocular reflex and nystagmus
Alport syndrome
Homocystinuria
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Anatomy and physiology of the eye
Eye and ear histology
Eye conditions: Retinal disorders: Pathology review
Anatomy of the eye
Eye conditions: Inflammation, infections and trauma: Pathology review
Development of the eye
Optic pathways and visual fields
Pediatric ophthalmological conditions: Clinical
Cataract
Glaucoma
Retinal detachment
Age-related macular degeneration
Diabetic retinopathy
Diabetic nephropathy
Anatomy clinical correlates: Eye
Uveitis
Photoreception
Congenital heart defects: Clinical
Congenital disorders: Clinical
Congenital gastrointestinal disorders: Pathology review
Club foot
Pediatric orthopedic conditions: Clinical
Osgood-Schlatter disease (traction apophysitis)
Lordosis, kyphosis, and scoliosis
Dislocated shoulder
Anatomy clinical correlates: Clavicle and shoulder
Patellofemoral pain syndrome
Rotator cuff tear
Bursitis
Seronegative and septic arthritis: Pathology review
Seronegative arthritis: Clinical
Rheumatoid arthritis: Clinical
Rheumatoid arthritis and osteoarthritis: Pathology review
Septic arthritis
Rheumatoid arthritis
Reactive arthritis
Psoriatic arthritis
Juvenile idiopathic arthritis
Subacute granulomatous thyroiditis
Radial head subluxation (Nursemaid elbow)
Anatomy of the knee joint
Meniscus tear
Anterior cruciate ligament injury
Osteoarthritis
Joint pain: Clinical
Temporomandibular joint dysfunction
Patellar tendon rupture
Muscle spindles and golgi tendon organs
Baker cyst
Deep vein thrombosis and pulmonary embolism: Pathology review
Spondylolysis
Spondylolisthesis
Lower back pain: Clinical
Spondylosis
Spondylitis
Muscles of the back
Legg-Calve-Perthes disease
Cleidocranial dysplasia
Metaplasia and dysplasia
Developmental dysplasia of the hip
Achilles tendon rupture
Charcot-Marie-Tooth disease
Anatomy of the foot
Joints of the ankle and foot
Flat feet
Genu valgum
Anatomy clinical correlates: Foot
Sprained ankle
Attention deficit hyperactivity disorder
Generalized anxiety disorder
Sleep disorders: Clinical
Major depressive disorder
Social anxiety disorder
Disruptive, impulse-control and conduct disorders: Clinical
Obsessive compulsive disorders: Clinical
Obsessive-compulsive disorder
Personality disorders: Clinical
Somatic symptom disorders: Clinical
Panic disorder
Mood disorders: Pathology review
Mood disorders: Clinical
Major depressive disorder with seasonal pattern
Cluster B personality disorders
Childhood and early-onset psychological disorders: Pathology review
Delirium
ADHD: Information for patients and families (The Primary School)
Psychomotor stimulants
Sympatholytics: Alpha-2 agonists
Neurodevelopmental disorders: Clinical
Autism spectrum disorder
Substance misuse and addiction: Clinical
Cocaine use disorder
Suicide
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Local anesthetics
Tobacco use disorder
Malingering, factitious disorders and somatoform disorders: Pathology review
Somatic symptom disorder
Cluster C personality disorders
Cluster A personality disorders
Eating disorders: Clinical
Body focused repetitive disorders
Delusional disorder
Schizophrenia spectrum disorders: Clinical
Schizophrenia
Lithium
Atypical antipsychotics
Typical antipsychotics
Schizophrenia spectrum disorders: Pathology review
Personality disorders: Pathology review
Disruptive, impulse control, and conduct disorders
Post-traumatic stress disorder
Trauma- and stress-related disorders: Pathology review
Stress
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Selective serotonin reuptake inhibitors
Medications for neurodegenerative diseases
Atypical antidepressants
Anticonvulsants and anxiolytics: Benzodiazepines
Toxidromes: Clinical
Insomnia
Gout
Gout and pseudogout: Pathology review
Non-steroidal anti-inflammatory drugs
Antigout medications
Lupus nephritis
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Fibromyalgia
Myalgias and myositis: Pathology review
Intracerebral hemorrhage
Subarachnoid hemorrhage

Transcript

Watch video only

Migraine medications include a wide variety of drugs used to treat a specific type of headache called migraine.

Migraines are the second most common primary headache.

They’re often preceded by symptoms like irritability, depression, and fatigue that can begin hours to days before the headache itself. Sometimes there can be an aura where people experience strange smells, lights, visual disturbances, or even hallucinations before the onset of the migraine.

The migraine itself usually feels like a pounding or pulsating, typically localized to one side of the head and can last from hours to days.

As if this was not bad enough, these headaches tend to come with nausea and vomiting, irritability, and pain or discomfort with lights, sounds, and smells called photophobia, phonophobia, and osmophobia, respectively.

During childhood, individuals can have nausea and vomiting without the headaches; and that’s called an abdominal migraine.

After a migraine is over, it can leave people feeling sore at the location of the pain and generally fatigued.

To remember the main features of migraines, you can use the mnemonic POUND, where P stands for pulsatile headache, O stands for one-day duration, U stands for unilateral, N for nausea, and D for disabling.

Although the underlying mechanism causing migraines isn’t well understood, there are some clues.

Concentrations of the neurotransmitter, serotonin, increase during the aura, triggering vasoconstriction, and then decrease to lower-than-normal levels during the migraine attack, triggering vasodilation. This change in the blood vessel size may be a trigger for pain receptors, causing the headache.

The initial vasoconstriction may also trigger cortical spreading depression, which is a phenomenon when the brain becomes hypersensitive to certain stimuli like lights, sounds, and smells.

Migraines are often associated with specific triggers like the smell of cigarette smoke, foods like chocolate or cheese, and drinking wine.

Even sleeping too much or too little can sometimes trigger a migraine.

There are two treatment approaches for migraine: acute treatment to help manage the pain; and preventive treatment to keep headaches from happening in the first place, in individuals that have severe, debilitating headaches.

The acute treatment includes common analgesic drugs, triptans, and ergot alkaloids.

For people with mild or moderate symptoms, initial treatment may involve only analgesics, such as NSAIDs or the opioid agonist butorphanol.

Acutely, pain medications work best if they’re used at the first sign of an attack, during the early symptoms, and aura.

If the pain is very severe, triptans or ergotamine, which are serotonin agonists, can be useful because they mimic serotonin to cause vasoconstriction.

So, triptans should be prescribed when people with mild symptoms don’t respond to analgesics, or when symptoms are moderate to severe.

The common suffix for these medications is -triptan, like sumatriptan, zolmitriptan, naratriptan, or rizatriptan.

All of them can be given by mouth, but this may be impractical for people who have nausea or vomiting during the attack. For these situations, subcutaneous injections or a nasal spray of sumatriptan are available.

Triptans are agonists at 5-HT1B and 5HT1D serotonin receptors, therefore preventing vasoactive peptide release, reducing trigeminal nerve activation, and causing vasoconstriction.

Side effects are generally mild, and include mild pain or burning sensations at the site of injection, paresthesia, fatigue, or dizziness, when given per orally.

In addition, not only do they cause vasoconstriction on the blood vessels in the brain, but also in other blood vessels, which can raise blood pressure.

Also, as it causes coronary vasospasm, it can bring about a type of chest pain called angina. Although it’s an uncommon side effect, that’s why triptans are contraindicated in people with hypertension, coronary artery disease, prinzmetal angina, and peripheral vascular disease.

It can also rarely cause myocardial ischemia or infarction, and arrhythmias as well.

Now, when used together with other serotonin receptor agonists, triptans can induce a serotonin syndrome, that comprises of cognitive symptoms, like headache, hallucinations, or coma; somatic symptoms, like tremors or hyperreflexia; and autonomic symptoms like tachycardia, nausea, diarrhoea, shivering, and sweating. So, people who have recently been given ergot alkaloids or other serotonin agonists mustn’t use triptans, at least for 24 hours.

Okay so, sometimes, NSAIDs or triptans aren’t effective to relieve the symptoms. So we can move on to the ergot alkaloids, or simply ‘ergots’, which include ergotamine and dihydroergotamine.

Ergotamine can be administered in sublingual tablets, and dihydroergotamine can be injected or used as a nasal spray.

Ergots are also agonist at 5-HT serotonin receptors. However, they're not specific for 5-HT1 receptors, and that means they have more side effects than triptans.

For example, when they stimulate 5HT3 receptors in the vomiting center of the brain, they can trigger nausea or vomiting.

Also, just like triptans, ergot alkaloids causes vasoconstriction and are contraindicated in people with coronary artery disease or hypertension.

In a similar aspect, as ergot stimulate contraction of the smooth muscle in the wall of blood vessels, they also stimulate contraction of the uterine smooth muscle, an oxytocic effect that can lead to premature labor in pregnant women, causing fetal distress and miscarriage. So, they’re contraindicated during pregnancy.

Ergot alkaloids are widely metabolized in the liver, that’s why they’re contraindicated in patients with liver impairment.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Treatment of acute migraine headache" Am Fam Physician (2011)
  5. "Migraine Headache Prophylaxis" Am Fam Physician (2019)
  6. "Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date" Clin Pharmacol Drug Dev (2017)
  7. "Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences" Expert Review of Neurotherapeutics (2013)
  8. "The pathophysiology of migraine: implications for clinical management" Lancet Neurol (2018)